Variables | Total (N = 1802) | Men (N = 1312) | Women (N = 490) | p-value | |||
---|---|---|---|---|---|---|---|
N | (%) | N | (%) | N | (%) | ||
Age (years) | |||||||
> 50 | 1158 | (64.2) | 828 | (45.9) | 330 | (67.3) | < 0.001 |
> 60 | 634 | (35.2) | 464 | (35.4) | 170 | (34.7) | 0.790 |
Comorbidities | |||||||
Hypertension | 691 | (38.3) | 500 | (38.1) | 191 | (39.0) | 0.735 |
Diabetes | 280 | (15.5) | 151 | (11.5) | 129 | (26.3) | < 0.001 |
Dyslipidemia | 150 | (8.3) | 93 | (7.1) | 57 | (11.6) | 0.002 |
Gout | 367 | (20.4) | 293 | (22.5) | 74 | (15.1) | 0.001 |
Hyperuricemia | 267 | (14.8) | 197 | (15.0) | 70 | (14.3) | 0.698 |
Obesity (BMI > 27) | 446 | (24.8) | 322 | (24.5) | 124 | (25.3) | 0.738 |
Stone composition | |||||||
CaO | 1109 | (61.5) | 844 | (64.3) | 265 | (54.1) | < 0.001 |
CaO-CaP | 165 | (9.2) | 114 | (8.7) | 51 | (10.4) | 0.260 |
Apatite | 280 | (15.5) | 147 | (11.2) | 133 | (27.1) | < 0.001 |
Brushite | 11 | (0.6) | 9 | (0.7) | 2 | (0.4) | 0.501 |
Uric acid | 126 | (7.0) | 105 | (8.0) | 21 | (4.3) | 0.006 |
Struvite | 108 | (6.0) | 91 | (7.0) | 17 | (3.4) | 0.005 |
Cystine | 3 | (0.2) | 2 | (0.2) | 1 | (0.2) | 0.811 |
Surgery of stone acquisition | |||||||
PCNL | 349 | (19.4) | 237 | (18.0) | 112 | (22.8) | 0.022 |
URSL | 846 | (46.9) | 573 | (43.7) | 273 | (55.7) | < 0.001 |
Cystolithotripsy | 374 | (20.8) | 335 | (25.5) | 39 | (8.0) | < 0.001 |
Self-voiding after ESWL | 181 | (10.0) | 124 | (9.5) | 57 | (11.6) | 0.170 |
Self-voiding | 52 | (2.9) | 33 | (2.5) | 19 | (3.8) | 0.124 |